Results 111 to 120 of about 6,767 (186)

Eltrombopag Combined With Cyclosporine A in the Treatment of Pediatric Patients With SAA: Establishing the Range for Eltrombopag Concentrations. [PDF]

Clin Transl Sci
Li F, Li N, Tang X, Huang T, Li L, Li H, Ren D, Tu C, Li D.   +8 more
europepmc   +1 more source

Hematopoietic stem and progenitor cell hierarchy is established by thrombopoietin-driven neonatal hematopoiesis. [PDF]

Stem Cell Reports
Mochizuki-Kashio M, Yahagi A, Yokomizo T, Umemoto T, Suda T, Nakamura-Ishizu A.   +5 more
europepmc   +1 more source

Thrombocytosis in cancer patients: when more is not better-in fact, the opposite. [PDF]

Cancer Metastasis Rev
Aleksandrowicz K, Polityńska B, Kruszewska J, Radziwon P, Wojtukiewicz AM, Honn KV, Wojtukiewicz MZ.   +6 more
europepmc   +1 more source

Successful treatment of refractory cancer therapy-induced thrombocytopenia in a breast cancer patient using romiplostim N01: A case report. [PDF]

Medicine (Baltimore)
Liu P, Dong E, Jiang Y, Chen L, Xie B, Ling J.   +5 more
europepmc   +1 more source

Multiple Mammalian Cytokines and Erythropoietin-Mimetic Peptides Protect Insect Neurons via Phylogenetically Conserved Cytokine Receptor-Like Factor 3 (CRLF3). [PDF]

J Neurochem
Hahn N, Knorr DY, Twellsieck B, Huang R, Trebilcock A, Schwedhelm-Domeyer N, Pauls S, Werven LV, Jahn O, Ehrenreich H, Heinrich R.   +10 more
europepmc   +1 more source

Beyond Thrombopoiesis: The Immune Functions of Megakaryocytes in Bacterial Infections and Sepsis. [PDF]

Int J Mol Sci
Leardini-Tristão M, Banerjee M.
europepmc   +1 more source

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report. [PDF]

BMJ Open
Huang X, Liao X, Huang Y, Zhang C, Wang Z, Yu L.   +5 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists for the treatment of ITP.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources

Refractory ITP: revisiting definitions, diagnostics, and management paradigms. [PDF]

Hematology Am Soc Hematol Educ Program
Panch SR, Raman G, Bussel JB.
europepmc   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients. [PDF]

Am J Hematol
Marques C, Moulis G, Roussotte M, Bonnotte B, Viallard JF, Graveleau J, Lobbes H, Costedoat-Chalumeau N, Deroux A, Gobert D, Dossier A, Gilardin L, Lambotte O, Dufrenoy M, Mahévas M, Michel M, Sève P, Godeau B.   +17 more
europepmc   +1 more source